Its subsidiary, Biocon Pharma, also secured approval for the 6 mg/ml injectable formulation in pre-filled pens and cartridges
Before acting on mochi vs ro, keep switching, dosing, and safety decisions tied to licensed-provider review
Found's clinicians are trained in obesity medicine and use your MetabolicPrint Found's proprietary tool for understanding how your body processes food, responds to medication, and regulates weight to determine whether semaglutide is the right fit and to personalize your dose over time
#HealthcareInnovation #ObesityCare #ChronicDisease #Pharma #GLP1 #PublicHealth #IndiaHealthcare #HealthEquity #LifeSciences #FutureOfMedicine News source credits: LIVEMINT ( To view or add a comment, sign in 271 followers
You won't get paid for the drug
And emerging research suggests they might even slow the rate of memory loss among people diagnosed with Alzheimers